Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Glenmark
Glenmark
BSE: 532296NSE: GLENMARKISIN: INE935A01035

4th-Jun-2014 10:33Source: BSE

Glenmark - Glenmark Pharmaceuticals inaugurates new Antibody Manufacturing Facility in La Chaux-de-Fonds, Switzerland

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated June 04, 2014 titled "Glenmark Pharmaceuticals inaugurates new Antibody Manufacturing Facility in La Chaux-de-Fonds, Switzerland"

Sections
Follow us on
Available On
PCI DSS Compliant